Clinical Trial

To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects

Name: To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects — clinical trial record (NCT06543459)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated August 9, 2024 (before its estimated September 27, 2024 completion). Its status may not reflect the trial's current state.

Summary

A Concentration-QT Interval Correction (C-QTc) study of MY008211A Tablets in Healthy Subjects

Trial Details

NCT Number	NCT06543459
Lead Sponsor	Wuhan Createrna Science and Technology Co., Ltd
Conditions	Paroxysmal Nocturnal Hemoglobinuria
Enrollment	16 participants
Start Date	2024-08-10
Primary Completion	2024-09-27 (estimated)
Study Completion	2024-12-13 (estimated)
Updated on ClinicalTrials.gov	2024-08-09